Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
770.25%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 5.35Close
$ 4.18 - $ 7.23 52-Week Range
Ticker Information
Ticker
ABEOCompany Name
ABEONA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABEONA THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABEO - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.08M | 770.25% | $ 400K |
| 3/31/2025 | $ 3M | 0% | $ 0 |
| 12/31/2024 | $ 2.91M | 0% | $ 0 |
| 9/30/2024 | $ 2.85M | 0% | $ 0 |
| 6/30/2024 | $ 2.88M | 0% | $ 0 |
| 3/31/2024 | $ 3.03M | 86.69% | $ 3.5M |
| 12/31/2023 | $ 3.2M | 91.37% | $ 3.5M |
| 9/30/2023 | $ 3.49M | 97.7% | $ 3.57M |
| 6/30/2023 | $ 3.82M | 107.06% | $ 3.57M |
| 3/31/2023 | $ 4.35M | 407.49% | $ 1.07M |
Key Performance Insights, Last 5 Years
- ABEONA THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 106.11%.
- Over the past 5 years, ABEONA THERAPEUTICS INC's average DepAmor % has been 173.88%.
- The median DepAmor % for ABEONA THERAPEUTICS INC during this period was 108.33%
- ABEONA THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 770.25%.
- The lowest DepAmor % recorded by ABEONA THERAPEUTICS INC in the same timeframe 43.76%
ABEONA THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ABEONA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 7.43M ] / Revenues [ $ 7M ]
(=) DepAmor % [ 106.11% ] ABEO - Depreciation and Amortization Margin, Last 5 years
43.76%
Minimum
Mar 31, 2021
770.25%
Maximum
Jun 30, 2025
173.88%
Average
108.33%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |